Agreed. Major clinical goals still to be achieved. Hoping for better in 2015. Merry Christmas and best wisshes for the new year, to Bill and the whole Board!
You should be glad that they did not loot the company by giving each other huge cash bonus.. Last time when they issued a huge option package in August to Barr Or (at $6.48), there were a serious of PRs that moved the stock to almost 8.. Look for a similar PR Pumping , thought market may be wiser this times
Smells bad, SuperSmelly,
Dead on arrival drugs don't petition for rescue drug and priority review status. Optina will likely carry those designations as the NDA gets pushed through, so unless you wish to share anything to the contrary, you shall remain a smelly fella.
Fair point. The secondary was certainly fortuitous, but a 23% bonus seems extreme. I view the salary as in alignment with non-revenue biotech CEOs with no PhD or MD or track record of bringing products to market. He's in the black since he's been in at much lower strikes, unlike many of us. Usually a BOD will grant such an increase when major goals have been achieved. Luoxis and Ampion production facility (and no debt, ok capital) are good. STEP, Optina, Zertane, 12-wk hi-res MRI and general communications (except Letter to Shareholders) poor.
Either way, nothing can be done about it. If price is 3x higher in June, more power to him.
Let's remember he got the capital raise done at a good valuation. Without that capital raise, company might not be here today given the screw up with STEP. i don't mind the option grant to MM given his low salary as well. I think interests are well aligned here.
I always question to use options as compensation in bio industry as it is too easy manipulate stock price lower to give management a good exercise price. No matter how cheap they get, their options will sink with the boat too.
Who are you but a pseudo scientist, the last worthwhile data you had on Ampio drugs was at the time you were long, when you went short you messed up the board with Funk, when people call you on it you blame: "hyperbole adn uninformed conjecture" Right...
How did that goat study conclude Funkmeister?
It is always done that a company goes silent a week or so before a meeting with the FDA. The trial was adequately powered and completed. The CRO will present the findings with Bar Or and Mac present with the FDA where Mac will petition to have Optina registered under rescue drug status with priority review. This is fact and in the public domain. How do you argue against what we know?
In fact your arguments are fiction and we have called you our repeatedly with facts and your Funk persists?
And, we can add the fact that Optina was dropped from the most recent investor presentation. That is never done with key pipeline drugs.
Open MBs abound with fools, both pro and con, but there are still enough reasoned posters here to hold an occasional intelligent dialogue. Many more are residing in the background.
The fools might even make money here, but they will remain fools. The story for Ampion is still intact, so this almost certainly will have a higher value in 2015 than where we are today, regardless of hyperbole and uninformed conjecture.
Manipulation in a different form:
500/5600 where a stack on the offer indicates selling pressure, however that offer is retracted and that spoofing is fake as well. How is a 500 share purchase going to compete with 5600 offered? The buyer can't. If the offer was flashed and pulled then the offer might really be 300 shares from someone in Kansas and he just got dominated by a large albeit fake order and mr. Kansas does not get executed.
So the stock remains untraded for that period. The normal order flow was interrupted at a pre planned time to stop a further increase in the shareprice.
Daylight is a very strong disinfectant
Funkmeister# 10 aka. CrustyDeed. I provide facts, while Bill has become known as a deceptive pseudo scientist. When he in fact lied about Optina this morning the price dropped, it was the first leg down today, and you and others can see for yourself. When I pointed out the fact that he lied this morning, the stock resumed it's trend higher, these are the facts and can be seen in real time just looking at the daily chart and times of posts. So if you back up Bill as a thoughtful analysis then I must conclude as will others that you are in fact a Funkmeister.
The only way this board will ever get back to normal is if you disappear. Bill provides thoughtful analysis on a regular basis. You provide mindless, repetitive, paranoid posts that clutter the board and degrade the quality of every attempt at a meaningful conversation. Your choice of words hints that you are not even 20 years age let alone having 21 years of experience. Congrats on your first conversation with a CEO, now take your 439 shares of AMPE and go pump on StockTwits where your meaningless posts will be limited to 140 characters.
First of all there is nothing wrong with Optina. Bill picks on Optina with bad data for months now. When the OptinaEyes trial meeting with the FDA in first week or so of January, when that data becomes available right after that I would think that would be the last we ever hear of wild Bill. I suspect half of the haters on this board would bail as well.
Secondly, when Ampion data is further read anytime on the Super 7 or later on Stride and Strut, I would hope the other half of the hater population would move on as well...... then this board gets back to normal, without the deception, distraction, demeaning, distortion. This is how the board was back in the day of Elena_Cherry where that poster provided actual data to chew on, remember her Super?
...we've heard for months now ad nauseum how Optina is inferior and will fail(who cares), but I've requested some of your astute research for Ben Gay, Advil, Heating Pads, Weight Loss, Icy Hot & WD-40 etc. for OAK, and have yet to hear you impart your wisdom upon us.